Treatment w/ Tri-Luma® Cream & Intense Pulsed Light (IPL) vs a Mild Inactive Control Cream & Intense Pulsed Light (IPL) in Melasma

NCT00669071 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

56

Enrollment

INDUSTRY

Sponsor class

Stopped Enrollment closed

Conditions

Melasma

Interventions

DRUG: Fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%
DRUG: Cetaphil® Moisturizing Cream as Inactive Control

Sponsor

Galderma R&D